Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement

REFERENCES

• Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22: 123–144
   PubMed Web of Science ®Google Scholar
• Bernheimer H, Birkmayer W, Hornykiewicz O. et al. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20: 415–455
   PubMed Web of Science ®Google Scholar
• Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitter in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement Disorder, Vol. 2, London: Butterworths, 1987: pp. 166-230
   Google Scholar
• Lindvall O. Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 2004; 1: 382–393
   PubMedGoogle Scholar
• Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710–719
   PubMed Web of Science ®Google Scholar
• Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403–414
   PubMed Web of Science ®Google Scholar
• Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002; 5: 627–628
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31–40
   PubMed Web of Science ®Google Scholar
• Lee SH, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18: 675–679
   PubMed Web of Science ®Google Scholar
• Zeng X, Cai J, Chen J, et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 2004; 22: 925–940
   PubMed Web of Science ®Google Scholar
• Yan Y, Yang D, Zarnowska ED, et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005; 23: 781–790
   PubMed Web of Science ®Google Scholar
• Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344–2349
   PubMed Web of Science ®Google Scholar
• Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002; 418: 50–56
   PubMed Web of Science ®Google Scholar
• Barberi T, Klivenyi P, Calingasan NY, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003; 21: 1200–1207
   PubMed Web of Science ®Google Scholar
• Takagi Y, Takahashi J, Saiki H, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. ] Clin Invest 2005; 115: 102–109
   PubMed Web of Science ®Google Scholar
• Kim DW, Chung S, Hwang M, et al. Stromal cell-derived inducing activity, nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells 2006; 24: 557–567
   PubMedGoogle Scholar
• Nishimura F, Yoshikawa M, Kanda S,et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 2003; 21: 171–180
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gomez JA, Lu JQ, Velasco I, et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007; 25: 918–928
   PubMed Web of Science ®Google Scholar
• Sanchez-Pernaute R, Studer L, Ferrari D, et al. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno1) after transplantation. Stem Cells 2005; 23: 914–922
   PubMedGoogle Scholar
• Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 2004; 22: 1246–1255
   PubMed Web of Science ®Google Scholar
• Park CH, Minn YK, Lee JY, et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. Neurochem 2005; 92: 1265–1276
   PubMed Web of Science ®Google Scholar
• Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006; 24: 1433–1440
   PubMed Web of Science ®Google Scholar
• Roy NS, Cleren C, Singh SK, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006; 12: 1259–1268
   PubMed Web of Science ®Google Scholar
• Lavoir MC, Weier J, Conaghan J, et al. Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reprod Biomed Online 2005; 11: 740–744
   PubMedGoogle Scholar
• Wakayama S, Suetsugu R, Thuan NV, et al. Establishment of mouse embryonic stem cell lines from somatic cell nuclei by nuclear transfer into aged, fertilization-failure mouse oocytes. Curr Biol 2007; 17: R120—R121
   Google Scholar
• Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313–317
   PubMed Web of Science ®Google Scholar
• Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318–324
   PubMed Web of Science ®Google Scholar
• Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864–9869
   PubMed Web of Science ®Google Scholar
• Magliocca JF, Held IK, Odorico JS. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocom-patibil ity complex antigen expression. Stem Cells Dev 2006; 15: 707–717
   PubMedGoogle Scholar
• Li L, Baroja ML, Majumdar A, et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22: 448–456
   PubMed Web of Science ®Google Scholar
• Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24: 221–229
   PubMed Web of Science ®Google Scholar
• Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplanta-tion into ischemic myocardium. Circulation 2005; 112 (Suppl. I): S166—S172
   Google Scholar
• Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB 1 2007; 21: 1345–1357
   PubMed Web of Science ®Google Scholar
• Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372–376
   PubMed Web of Science ®Google Scholar
• Hooper M, Hardy K, Handyside A, et al. HPRT-deficient (Lesch—Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 1987; 326: 292–295
   PubMed Web of Science ®Google Scholar
• Akasaki Y, Black KL, Yu JS. Dendritic cell-based immu-notherapy for malignant gliomas. Expert Rev Neurother 2005; 5: 497–508
   PubMedGoogle Scholar
• Mrass P, Weninger W. Immune cell migration as a means to control immune privilege: Lessons from the CNS and tumors. Immunol Rev 2006; 213: 195–212
   PubMed Web of Science ®Google Scholar